Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Payables (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Payables for 14 consecutive years, with $552332.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Payables fell 25.81% year-over-year to $552332.0, compared with a TTM value of $552332.0 through Dec 2025, down 25.81%, and an annual FY2025 reading of $1.0 million, down 1.83% over the prior year.
  • Payables was $552332.0 for Q4 2025 at Neuroone Medical Technologies, down from $1.0 million in the prior quarter.
  • Across five years, Payables topped out at $1.0 million in Q3 2024 and bottomed at $296410.0 in Q2 2021.
  • Average Payables over 5 years is $714924.6, with a median of $759630.0 recorded in 2023.
  • The sharpest move saw Payables surged 194.99% in 2023, then crashed 38.4% in 2025.
  • Year by year, Payables stood at $703718.0 in 2021, then increased by 22.44% to $861638.0 in 2022, then fell by 11.8% to $760000.0 in 2023, then dropped by 2.04% to $744525.0 in 2024, then dropped by 25.81% to $552332.0 in 2025.
  • Business Quant data shows Payables for NMTC at $552332.0 in Q4 2025, $1.0 million in Q3 2025, and $467734.0 in Q2 2025.